A Leavitt

Summary

Country: Israel

Publications

  1. ncbi First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States
    Shiri Navon-Venezia
    Division of Epidemiology, Tel Aviv Sourasky Medical Center, Israel
    Antimicrob Agents Chemother 53:818-20. 2009
  2. ncbi Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel
    Shiri Navon-Venezia
    Division of Epidemiology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    J Antimicrob Chemother 62:289-95. 2008
  3. ncbi High tigecycline resistance in multidrug-resistant Acinetobacter baumannii
    Shiri Navon-Venezia
    The Laboratory for Molecular Epidemiology and Antibiotic Research, Department of Epidemiology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    J Antimicrob Chemother 59:772-4. 2007
  4. ncbi Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel
    Shiri Navon-Venezia
    Division of Epidemiology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel
    Antimicrob Agents Chemother 50:3098-101. 2006
  5. ncbi Evaluation of an accelerated protocol for detection of extended-spectrum beta-lactamase-producing gram-negative bacilli from positive blood cultures
    Shiri Navon-Venezia
    Molecular Epidemiology Laboratory, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, 6 Weizman St, Tel Aviv 64239, Israel
    J Clin Microbiol 43:439-41. 2005
  6. ncbi Protocol for the accelerated detection of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains from blood cultures
    S Navon-Venezia
    Laboratory for Molecular Epidemiology and Antimicrobial Resistance, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv 64239, Israel
    Eur J Clin Microbiol Infect Dis 23:200-2. 2004
  7. ncbi Failure of broth-based tests to detect methicillin-resistant Staphylococcus aureus in a clinical specimen
    M J Schwaber
    Division of Epidemiology and Laboratories of Molecular Epidemiology and Microbiology, Tel Aviv Sourasky Medical Center, 6 Weizmann St, Tel Aviv, 64239, Israel
    Eur J Clin Microbiol Infect Dis 23:348-51. 2004
  8. ncbi Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital
    R Ben-Ami
    Department of Infectious Diseases, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Clin Infect Dis 42:925-34. 2006
  9. ncbi Prevalence and genetic relatedness of community-acquired methicillin-resistant Staphylococcus aureus in Israel
    G Regev-Yochay
    Infectious Diseases Unit, Sheba Medical Center, Ramat Gan, Israel
    Eur J Clin Microbiol Infect Dis 25:719-22. 2006
  10. ncbi A candidate prostate cancer susceptibility gene at chromosome 17p
    S V Tavtigian
    Myriad Genetics, Inc, Salt Lake City, Utah, USA
    Nat Genet 27:172-80. 2001

Collaborators

Detail Information

Publications10

  1. ncbi First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States
    Shiri Navon-Venezia
    Division of Epidemiology, Tel Aviv Sourasky Medical Center, Israel
    Antimicrob Agents Chemother 53:818-20. 2009
    ..The threat of the global spread of hyperepidemic, extensively drug-resistant bacterial strains should be recognized and confronted...
  2. ncbi Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel
    Shiri Navon-Venezia
    Division of Epidemiology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    J Antimicrob Chemother 62:289-95. 2008
    ..We aimed to describe the occurrence and to understand the dissemination of this extended-spectrum beta-lactamase family among Enterobacteriaceae strains in our hospital...
  3. ncbi High tigecycline resistance in multidrug-resistant Acinetobacter baumannii
    Shiri Navon-Venezia
    The Laboratory for Molecular Epidemiology and Antibiotic Research, Department of Epidemiology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    J Antimicrob Chemother 59:772-4. 2007
    ..We aimed to evaluate the in vitro activity of tigecycline against MDR A. baumannii clones isolated before tigecycline was used in our institution...
  4. ncbi Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel
    Shiri Navon-Venezia
    Division of Epidemiology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel
    Antimicrob Agents Chemother 50:3098-101. 2006
    ..This is the first discovery of KPC-2 in E. coli and the first report of this enzyme originating outside the United States...
  5. ncbi Evaluation of an accelerated protocol for detection of extended-spectrum beta-lactamase-producing gram-negative bacilli from positive blood cultures
    Shiri Navon-Venezia
    Molecular Epidemiology Laboratory, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, 6 Weizman St, Tel Aviv 64239, Israel
    J Clin Microbiol 43:439-41. 2005
    ..Results of the direct ESBL testing were reported 2.3 days sooner and were comparable to those of the standard NCCLS method with sensitivity, specificity, and positive and negative predictive values of 100, 98, 94, and 100%, respectively...
  6. ncbi Protocol for the accelerated detection of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains from blood cultures
    S Navon-Venezia
    Laboratory for Molecular Epidemiology and Antimicrobial Resistance, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv 64239, Israel
    Eur J Clin Microbiol Infect Dis 23:200-2. 2004
    ..Use of this accelerated protocol may speed detection of the ESBL phenotype and thereby facilitate the early administration of appropriate antimicrobial therapy...
  7. ncbi Failure of broth-based tests to detect methicillin-resistant Staphylococcus aureus in a clinical specimen
    M J Schwaber
    Division of Epidemiology and Laboratories of Molecular Epidemiology and Microbiology, Tel Aviv Sourasky Medical Center, 6 Weizmann St, Tel Aviv, 64239, Israel
    Eur J Clin Microbiol Infect Dis 23:348-51. 2004
  8. ncbi Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital
    R Ben-Ami
    Department of Infectious Diseases, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Clin Infect Dis 42:925-34. 2006
    ..The influx of these bacteria into hospitals has major implications for infection-control and empirical treatment strategies...
  9. ncbi Prevalence and genetic relatedness of community-acquired methicillin-resistant Staphylococcus aureus in Israel
    G Regev-Yochay
    Infectious Diseases Unit, Sheba Medical Center, Ramat Gan, Israel
    Eur J Clin Microbiol Infect Dis 25:719-22. 2006
    ..Isolates were negative for pvl and were classified as ST-45-MRSA. Although CA-MRSA is still rare in Israel, the genetic relatedness of the strains found in this study to a successful MSSA clone warrants close follow up...
  10. ncbi A candidate prostate cancer susceptibility gene at chromosome 17p
    S V Tavtigian
    Myriad Genetics, Inc, Salt Lake City, Utah, USA
    Nat Genet 27:172-80. 2001
    ....